The initiative will be led by David Baker, 2024 Nobel Prize winner in Chemistry, IPD director, professor of biochemistry, and HHMI Investigator at the University of Washington
Strong performances in its Life Science, Healthcare and Electronics divisions — particularly Process Solutions, Cardiovascular treatments and Semiconductor Materials — powered the company’s results
Expands bioprocessing footprint across Asia
ALBIS will present a selection of advanced materials from its broad healthcare portfolio
Building a transparent, data-driven supply chain and self-reliant API ecosystem remains critical to reducing import dependence
The technology offers scalable continuous granulation at 200 kg/hour, with the potential to exceed 500 kg/hour for certain granules
Rising demands and advancements in eye care drive growth
The TPE Tourniquet and TPE Esmark Bandages are renowned for their single-use design,
Launch of new product range aligns with strategy to diversify into emerging applications with high growth potential
Combined capabilities to drive novel healthcare applications presented at MEDICA 2024
Subscribe To Our Newsletter & Stay Updated
